Monitor for the filing of the definitive merger proxy statement and the shareholder vote date. The deal premium suggests limited upside but downside if deal fails. Watch for regulatory review and potential competing bids.
Price Chart
Executive Summary
Organon filed additional definitive proxy soliciting materials (DEFA14A) containing a transcript of an all-employee town hall where management explains the rationale for the proposed acquisition by Sun Pharma for $14.00 per share in cash. This filing is part of the solicitation for shareholder approval of the merger.
Key Financial Metrics
Key Facts
- Merger agreement with Sun Pharma announced on April 27, 2026, for $14.00 per share in cash.
- Town hall transcript includes remarks from Executive Chair Carrie Cox and CEO Joe Morrissey supporting the deal.
- Board appointed Joe Morrissey as permanent CEO to lead through the transition.
- Organon acknowledges near-term debt challenges as a factor in the decision to sell.
Financial Impact
$14.00 per share in cash acquisition premium of 103% over prior close.
Risk Factors
- Regulatory approvals may not be obtained or may impose conditions.
- Shareholder vote may not be secured (though management support is strong).
- Integration risks and potential employee attrition.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182412 |
| Document: 0001193125-26-182412-index-headers.html | 0001193125-26-182412 |
| Document: 0001193125-26-182412-index.html | 0001193125-26-182412 |
| Document: 0001193125-26-182412.txt | 0001193125-26-182412 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 18, 2026 10w ago | Institutional Cluster | $13.68 | awaiting T+60 | — | $13.77 (−0.62%) |
Jul 31, 2026 12w ago | 8-K | $13.55 $13.74 | ▼ −1.40% | ▲ +1.05% | $13.77 (−1.59%) |
Jul 17, 2026 14w ago | 8-K | $13.49 $13.77 | ▲ +2.08% | ▼ −2.76% | $13.77 (+2.04%) |
Jun 17, 2026 18w ago | DEFM14A | $13.42 $13.64 | ▲ +1.64% | ▼ −1.51% | $13.77 (+2.57%) |
Jun 11, 2026 19w ago | DEFA14A | $13.45 $13.78 | ▲ +2.45% | ▼ −1.94% | $13.77 (+2.34%) |
Jun 1, 2026 21w ago | PREM14A | $13.37 $13.75 | ▲ +2.84% | ▲ +1.87% | $13.77 (+2.99%) |
Apr 30, 2026 25w ago | DEFA14A | $13.25 $13.52 | ▲ +2.08% | ▼ −0.74% | $13.77 (+3.93%) |
Apr 30, 2026 25w ago | 8-K | $13.25 $13.52 | ▼ −2.08% | ▲ +0.74% | $13.77 (−3.93%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.77 (+3.38%) |
Apr 27, 2026 26w ago | DEFA14A | $13.32 $13.56 | ▲ +1.84% | ▼ −1.88% | $13.77 (+3.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers